BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25599996)

  • 21. Mesothelioma at era of helical tomotherapy: results of two institutions in combining chemotherapy, surgery and radiotherapy.
    Sylvestre A; Mahé MA; Lisbona A; Zefkili S; Savignoni A; Bonnette P; Barthes Fle P; Paris E; Perigaud C; Yassa M; Giraud P
    Lung Cancer; 2011 Dec; 74(3):486-91. PubMed ID: 21663996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
    Giraud P; Sylvestre A; Lisbona A; Zefkili S; Bonnette P; Le Pimpec Barthes F; Michaud JL; Perigaud C; Mahé MA
    Rev Mal Respir; 2011 May; 28(5):609-17. PubMed ID: 21645831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
    Ishibashi H; Kobayashi M; Takasaki C; Okubo K
    Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Yajnik S; Rosenzweig KE; Mychalczak B; Krug L; Flores R; Hong L; Rusch VW
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1319-26. PubMed ID: 12873676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy for malignant pleural mesothelioma.
    Rosenzweig KE; Giraud P
    Cancer Radiother; 2017 Feb; 21(1):73-76. PubMed ID: 28237609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Rice DC; Stevens CW; Correa AM; Vaporciyan AA; Tsao A; Forster KM; Walsh GL; Swisher SG; Hofstetter WL; Mehran RJ; Roth JA; Liao Z; Smythe WR
    Ann Thorac Surg; 2007 Nov; 84(5):1685-92; discussion 1692-3. PubMed ID: 17954086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-institution experience of intensity-modulated radiotherapy for malignant pleural mesothelioma at University of Catania.
    Spatola C; Militello C; Tocco A; Salamone V; Luigi R; Migliore M; Marletta D; Cannizzaro A; Bevilacqua R; Milone P; Pergolizzi S; Privitera G
    Future Oncol; 2018 Mar; 14(6s):17-21. PubMed ID: 29400553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
    Ahamad A; Stevens CW; Smythe WR; Vaporciyan AA; Komaki R; Kelly JF; Liao Z; Starkschall G; Forster KM
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):768-75. PubMed ID: 12573764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of malignant pleural mesothelioma treatment in Japan: Patterns of practice and clinical outcomes in tomotherapy facilities.
    Nakanishi-Imai M; Murai T; Onishi M; Mouri A; Komiyama T; Omura M; Kudo S; Miyamoto A; Hoshino M; Ogawa S; Ohashi S; Koizumi M; Omagari J; Mayahara H; Karasawa K; Okumura T; Shibamoto Y
    J Radiat Res; 2022 Mar; 63(2):281-289. PubMed ID: 35138408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.
    Rimner A; Zauderer MG; Gomez DR; Adusumilli PS; Parhar PK; Wu AJ; Woo KM; Shen R; Ginsberg MS; Yorke ED; Rice DC; Tsao AS; Rosenzweig KE; Rusch VW; Krug LM
    J Clin Oncol; 2016 Aug; 34(23):2761-8. PubMed ID: 27325859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesothelioma.
    Simon M; Shochat T; Peled N; Zer A; Kramer MR; Eldan O; Saute M; Dudnik ER; Allen AM
    Thorac Cancer; 2018 Nov; 9(11):1470-1475. PubMed ID: 30240138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
    Soldera SV; Kavanagh J; Pintilie M; Leighl NB; de Perrot M; Cho J; Hope A; Feld R; Bradbury PA
    Oncologist; 2019 Jul; 24(7):e510-e517. PubMed ID: 30478189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
    Baldini EH; Richards WG; Gill RR; Goodman BM; Winfrey OK; Eisen HM; Mak RH; Chen AB; Kozono DE; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1374-81. PubMed ID: 25772281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
    Flores RM; Krug LM; Rosenzweig KE; Venkatraman E; Vincent A; Heelan R; Akhurst T; Rusch VW
    J Thorac Oncol; 2006 May; 1(4):289-95. PubMed ID: 17409872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
    Miles EF; Larrier NA; Kelsey CR; Hubbs JL; Ma J; Yoo S; Marks LB
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1143-50. PubMed ID: 18262369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.